Treatment FAQ

how does tumor cell differentiation affect treatment

by Dr. Ewald Steuber Published 3 years ago Updated 2 years ago
image

Cancer stem cell differentiation therapy could attenuate the malignant potential of a tumor or suppress its aggressive behavior. It also offers a therapeutic strategy to deplete the CSC pool and eradicate cancer.Jun 22, 2020

What happens when cancer cells are poorly differentiated?

When cancer cells are poorly differentiated, it can complicate identifying the tissue they started in and targeting treatment. Many tumours are divided into three grades of differentiation. Tumours spread easier than other tumours, and their prognosis is a little worse than for others.

What are cancer differentiation grades?

Cancer differentiation grades refers to the graded classification of tumours, according to how differentiated the tumour is. Usually there are three or four grades. There are differences in cancer differentiation. A tumour that closely resembles the structure of the tissue it started in is described as very differentiated.

How does the type of cancer cell affect staging?

Because the type of cancer cell can affect treatment and outlook, it can be a factor in staging. For example, cancers of the esophagusare mainly either squamous cell cancers or adenocarcinomas. Squamous cell esophageal cancers are staged differently from esophageal adenocarcinomas.

Does cancer affect the cell cycle?

If you ask an oncologist – a doctor who treats cancer patients – she or he will likely answer with a resounding yes. Cancer is basically a disease of uncontrolled cell division. Its development and progression are usually linked to a series of changes in the activity of cell cycle regulators.

image

How does differentiation affect cancer?

In cancer, this describes how much or how little tumor tissue looks like the normal tissue it came from. Well-differentiated cancer cells look more like normal cells and tend to grow and spread more slowly than poorly differentiated or undifferentiated cancer cells.

Is there a role of cell differentiation in cancer diagnosis?

Abstract. Poor differentiation is an important hallmark of cancer cells, and differentiation therapy holds great promise for cancer treatment. The restoration of IkB kinase α (IKKα) leads to the differentiation of nasopharyngeal carcinoma cells with reduced tumorigenicity. The findings by Yan et al.

What happens when cell differentiation goes wrong?

Several types of cancer originate from the neural crest lineage, including tumors of the peripheral nervous system, some endocrine tumors and melanoma. Although cell specialization is a tightly controlled process, errors of differentiation can occur, giving rise to malignancy, the researchers said.

What is differentiation therapy in cancer?

Differentiation therapy is a method to treating advanced cancers in which malignant cells are encouraged to differentiate into more mature forms using pharmacological agents. The basis of the therapy stems from the tendency of malignant tumor cells to assume a less specialized, stem cell-like dedifferentiated state.

How is poorly differentiated carcinoma treated?

Patients with advanced poorly differentiated carcinoma should be considered for treatment with cisplatin-based combination chemotherapy, particularly if tumors occur predominantly in the mediastinum, retroperitoneum, or lymph nodes.

How does differentiation therapy work?

Differentiation therapy exerts its function by switching a malignant cancer cell into a benign phenotype as well as forcing CSCs to differentiate and lose their self-renewal properties.

What significance does differentiation have on prognosis?

In some cases, information about differentiation can influence the prognosis and inform the treatment decision. 11 In general, “well differentiated” translates to a lower grade cancer, while “poorly differentiated” translates to a higher-grade malignancy.

What does well differentiated tumor mean?

DIH-feh-REN-shee-AY-ted) A term used to describe cells and tissue that have mature (specialized) structures and functions. In cancer, well-differentiated cancer cells look more like normal cells under a microscope and tend to grow and spread more slowly than poorly differentiated or undifferentiated cancer cells.

Why are benign tumors well differentiated?

A benign tumor is well differentiated, grows slowly, shows expansile growth with encapsulation and does not metastasize. In contrast, a malignant tumor is often poorly differentiated, grows rapidly with many mitoses, shows invasive growth with no capsule and frequently metastasizes.

Why are poorly differentiated cancer cells worse?

Tumours that are undifferentiated or poorly differentiated tend to be more aggressive. They tend to grow more quickly, spread more often and have a worse prognosis than tumours with well-differentiated cancer cells.

What does poorly differentiated cancer cells mean?

High grade or grade III tumor cells are poorly differentiated. This means that the tumor cells don't look like normal cells. They're disorganized under the microscope and tend to grow and spread faster than grade I tumors.

What is meant by the term differentiation and why is it so important?

Differentiation in (developmental biology) refers to the normal process by which a less specialized cell undergoes maturation to become more distinct in form and function. It is also called cell differentiation.

What is tumor grade?

Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of...

How is tumor grade determined?

If a tumor is suspected to be malignant, a doctor removes all or part of it during a procedure called a biopsy . A pathologist (a doctor who ident...

How are tumor grades classified?

Grading systems differ depending on the type of cancer. In general, tumors are graded as 1, 2, 3, or 4, depending on the amount of abnormality. In...

What are some of the cancer type-specific grading systems?

Breast and prostate cancers are the most common types of cancer that have their own grading systems. Breast cancer . Doctors most often use the Not...

How does tumor grade affect a patient’s treatment options?

Doctors use tumor grade and other factors, such as cancer stage and a patient’s age and general health, to develop a treatment plan and to determ...

What is tumor grade?

Tumor grade is the description of a tumor based on how abnormal the tumor cells and the tumor tissue look under a microscope. It is an indicator of how quickly a tumor is likely to grow and spread. If the cells of the tumor and the organization of the tumor’s tissue are close to those of normal cells and tissue, ...

What is the NCI fact sheet?

The NCI fact sheet Pathology Reports describes the type of information that can be found in a pathologist’s report about the visual and microscopic examination of tissue removed during a biopsy or other surgery.

Why is tumor grade important?

The importance of tumor grade in planning treatment and determining a patient’s prognosis is greater for certain types of cancer, such as soft tissue sarcoma, primary brain tumors, and breast and prostate cancer.

What is the procedure called when a tumor is suspected to be malignant?

If a tumor is suspected to be malignant, a doctor removes all or part of it during a procedure called a biopsy. A pathologist (a doctor who identifies diseases by studying cells and tissues under a microscope) then examines the biopsied tissue to determine whether the tumor is benign or malignant. The pathologist also determines ...

What is the Nottingham grading system?

Doctors most often use the Nottingham grading system (also called the Elston-Ellis modification of the Scarff-Bloom-Richardson grading system) for breast cancer ( 1 ). This system grades breast tumors based on the following features: Tubule formation: how much of the tumor tissue has normal breast (milk) duct structures.

What is the grade of cancer?

Grading systems differ depending on the type of cancer. In general, tumors are graded as 1, 2, 3, or 4, depending on the amount of abnormality. In Grade 1 tumors, the tumor cells and the organization of the tumor tissue appear close to normal. These tumors tend to grow and spread slowly.

What is the primary pattern of prostate cancer?

The primary pattern represents the most common tissue pattern seen in the tumor, and the secondary pattern represents the next most common pattern. Each pattern is given a grade from 1 to 5, with 1 looking the most like normal prostate tissue and 5 looking the most abnormal.

What is the cancer that develops in lymphatic tissue called?

Cancer that develops in lymphatic tissue is called a lymphoma, while cancer that develops from bone marrow cancer is called leukaemia. Tumours are classified by histological type, meaning according to the type of tissue in which the tumour starts because, among other things, it affects the choice of treatment.

What is a tumour that closely resembles the structure of the tissue it started in?

A tumour that closely resembles the structure of the tissue it started in is described as very differentiated. Thus, the closer the structure of the cancer cell is to that of a normal cell structure, the better it is differentiated.

How does cancer affect the body?

Cancer begins to cause damage to the body by growing locally, metastasising in different organs and causing a variety of general symptoms. A malignant tumour can become sizeable at its primary site and harm the normal functioning of the organ in question. The tumour can also displace neighbouring organs, causing pain and pressure symptoms.

What is it called when a tumor resembles the original tissue?

A tumour that resembles the original tissue to a lesser extent is termed poorly differentiated, or anaplastic. When cancer cells are poorly differentiated, it can complicate identifying the tissue they started in and targeting treatment. Many tumours are divided into three grades of differentiation.

What are the different grades of cancer?

Mostly resembles normal tissue and usually has a good prognosis. Moderately differentiated, Grade 2. Intermediate forms of tumour with both good and bad prognosis. Badly differentiated, Grade 3 and undifferentiated, Grade 4.

What is the epithelium? What are some examples?

The epithelium covers the whole surface of the body and wraps all of its internal surfaces and cavities. The surface of the skin, mucosa, gastrointestinal tract and bladder are exampled of epithelial tissue. Cancer that develops from the epithelial tissue is a carcinoma. Cancer that develops from supportive tissue is a sarcoma.

What are the different types of tissue?

The body’s normal tissue types include: Epithelium (the outer layer of the skin and mucosa) Supportive tissue (bone, cartilage , connective tissue , muscle tissue) Nerve tissue. Lymphatic tissue. Bone marrow. The epithelium covers the whole surface of the body and wraps all of its internal surfaces and cavities.

What is the most common cancer grading system?

Breast and prostate cancers are the most common types of cancer that have their own grading systems. Breast cancer. Doctors most often use the Nottingham grading system (also called the Elston-Ellis modification of the Scarff-Bloom-Richardson grading system) for breast cancer.

What is a tumor grade?

Tumor grade is a classification system based on the appearance of tumor cells under the microscope. Cancer cells that are described as low-grade (grade 1) have an appearance similar to normal cells. High-grade (grade 3) cancer cells appear distinctly abnormal under the microscope. Low-grade tumors are often referred to as well-differentiated, ...

What does a score of 1 mean?

Each of the categories gets a score between 1 and 3; a score of "1" means the cells and tumor tissue look the most like normal cells and tissue, and a score of "3" means the cells and tissue look the most abnormal. The scores for the three categories are then added, yielding a total score of 3 to 9.

What is the NCCN risk stratification?

The NCCN guidelines stratify prostate cancer by risk. The risk groups are based on the staging of the prostate cancer, the Gleason score, PSA, and number and extent of biopsy cores positive for cancer. The risk stratification may help decide what treatment option is best for each individual.

What is the grade of cancer?

Grading systems differ depending on the type of cancer. In general, tumors are graded as 1, 2, 3, or 4, depending on the amount of abnormality. In Grade 1 tumors, the tumor cells and the organization of the tumor tissue appear close to normal. These tumors tend to grow and spread slowly.

What is the primary pattern of prostate cancer?

The primary pattern represents the most common tissue pattern seen in the tumor, and the secondary pattern represents the next most common pattern. Each pattern is given a grade from 1 to 5, with 1 looking the most like normal prostate tissue and 5 looking the most abnormal.

What is the difference between a high grade tumor and a low grade tumor?

Low-grade tumors are often referred to as well-differentiated, while high-grade tumors are called poorly differentiated or undifferentiated. Typically, high-grade tumors are more likely to grow and spread faster than low-grade tumors. Cancer is usually graded on a scale of 1-3, with 3 being the highest grade.

What are the implications of CSCs?

The existence of CSCs has profound implications for clinical oncology. One of them is concerned with the prediction of patient outcomes at the time of diagnosis. If tumor tissues vary in CSC content, then tumors containing a higher fraction of CSCs might be characterized by a more aggressive biology and worse clinical outcomes. Indeed, a number of studies have shown that tumors whose bulk gene expression profiles are similar to those of purified CSCs are associated with poor outcomes, likely reflecting a higher CSC content and a more immature differentiation state. This was first shown for breast cancer, using a 186-gene signature called the “invasiveness gene signature” (IGS), obtained by comparing the gene expression profile of breast CSCs with that of normal breast epithelial cells. 116 The IGS was used to stratify breast cancer patients with early-stage disease in different groups, based on the similarity of their whole tumor's gene expression profile with the IGS. Remarkably, high similarity to the IGS was associated with reduced overall and metastasis-free survival. Conceptually similar findings have also been observed across a variety of other cancer types, including leukemia, head and neck, bladder, and colon cancer. 95, 104, 117, 118, 119, 120

Why is CSC important in clinical oncology?

The identification of CSCs across many tumor types is key to the future development of clinical oncology, especially for the discovery of new predictive biomarkers and the design of novel antitumor agents. The study of CSCs, however, is technically challenging. CSCs often represent a minority of the cancer cell populations and need to be purified from primary tissues if their functional properties are to be evaluated in the context of their original tissue microenvironment. Future studies will need to devise new experimental platforms to address this challenge, such as single-cell genomics technologies, able to perform precise measurements on small biopsy samples and with single-cell resolution.95

Can cancer cells be transplanted in mice?

An alternative explanation for the fact that different subsets of cancer cells display different tumorigenic capacity when transplanted in immunodeficient mice could be that all cancer cells are actually tumorigenic, but only a specific subset, with a specific phenotype, is able to engraft in the mouse. The ability of purified cell populations to engraft in immunodeficient mice is dependent on many external variables, such as the purification and transplantation procedures, the degree of mouse immunodeficiency, the capacity of the cells to resist nutrient deprivation and induce neoangiogenesis, and the degree of cross talk between secreted growth factors and their receptors across mice and humans. 145 Despite this, multiple lines of evidence argue in support of the existence of CSCs across many forms of cancer. For example, lineage-tracing experiments have shown that human tumors engrafted in mice do recapitulate the cell composition and phenotypic diversity of the primary tumors from which they have been derived, and contain both tumorigenic and nontumorigenic populations. 95 This finding indicates that the mouse environment is compatible with multilineage differentiation processes and with survival of human nontumorigenic cancer cells. Most importantly, identical results can be reproduced using mouse-in-mouse tumors, with regard to in vivo lineage tracing experiments 105, 106, 146 and the existence of both tumorigenic and nontumorigenic cancer cell populations. 20, 147 In the case of mouse tumors, transplantation experiments are performed into syngeneic hosts, thus ruling out confounding effects from cross-species barriers, either biologic or immunologic; lineage-tracing experiments are performed in genetically engineered mice, in which primary tumors can be studied in situ, in the original location where they arise, thus ruling out transplantation artifacts. Among the advantages of lineage-tracing experiments performed in transgenic mouse models is the possibility to perform intravital imaging on primary tumors and follow the clonal growth dynamics of individual cancer cells in a time-lapse fashion. This is usually achieved by performing experiments in genetically engineered mice that enable the “tagging” of individual cancer cells with distinct fluorescent reporters. The results emerging from this generation of in vivo imaging experiments show that, within the same tumor, some cells are able to grow indefinitely, whereas others appear to gradually exhaust their proliferation capacity.146 Finally, the differences observed among cancer cells in the expression of lineage-restricted differentiation antigens do not appear to be caused by clonal differences in their repertoire of genetic mutations, as demonstrated by single-cell RNA-sequencing experiments in human primary oligodendrogliomas.107 Taken together, these findings support the idea that, as predicted by CSC models, tumors can retain elements of the hierarchic organization of their parent tissues.

How do tumors form?

Many human tumors originate from tissues that, as part of their normal physiology, undergo a process of constant turnover, sustained by minority populations of long-lived cells, called stem cells. In many tissues, stem cells are the only cells that can persist throughout the lifetime of the host, and therefore represent ideal targets for malignant transformation, because they can accumulate carcinogenic insults, such as genetic and epigenetic mutations, over long periods of time. Indeed, experimental evidence indicates that many forms of human cancer can be best understood as “aberrant organs” sustained in their growth and metastatic dissemination by a pathologic population of stemlike cells, originated as a result of mutations in genes that regulate key properties of the stem cell phenotype, such as the capacity for unlimited numerical expansion (self-renewal), the capacity to give rise to progenies of specialized cells (differentiation) and the capacity to migrate into new tissue locations and support tissue regeneration (tissue repair). This hypothesis is supported by the observation that, in many forms of human cancer, only a specific, phenotypically distinct, subset of cancer cells can form tumors when serially transplanted into immune-deficient mice (cancer stem cells), and implies that, to achieve cure, therapies must eradicate such subset of cancer cells. Studies on the gene-expression profile of cancer stem cell populations have led to the discovery of new prognostic biomarkers and pharmacological targets in cancer biology, and to the identification of tumor subtypes with differential response to anti-tumor drugs, opening new research avenues in clinical oncology.

What is cancer stage?

The cancer stage is also a way for doctors to describe the extent of the cancer when they talk with each other about a person’s cancer. Not all cancers are staged. For example, leukemias are cancers of the blood cells and therefore typically have spread throughout the body by the time they are found.

Why do we need a biopsy?

A biopsy often is needed to confirm a cancer diagnosis. Biopsies might also be needed to find out if a lump felt on an exam or if something seen on an imaging test in another part of the body is really from the spread of cancer. During a biopsy, the doctor removes a tumor or pieces of a tumor to be looked at in the lab.

What is the process of finding out how much cancer is in a person's body and where it’s located

Cancer Staging . Staging is the process of finding out how much cancer is in a person’s body and where it’s located. It’s how the doctor determines the stage of a person’s cancer.

What is it called when cancer is staged again?

When a cancer is staged again after the initial staging, it is sometimes referred to as restaging . Often the same tests that were done when the cancer was first diagnosed (such as physical exams, imaging tests, endoscopy exams, biopsies, and maybe surgery) are done again.

Why is cancer stage important?

A cancer’s stage can also be used to help predict the course it will likely take, as well as how likely it is that treatment will be successful. Although each person’s situation is different, cancers of the same type and stage tend to have similar outlooks. The cancer stage is also a way for doctors to describe the extent ...

How long do people live with cancer?

This is the percentage of people with a certain type and stage of cancer who are still alive a certain amount of time (usually 5 years) after being diagnosed. For example, if the 5-year survival rate for a certain stage of a type of cancer is 80%, it means that 80 out of 100 people who have that type and stage of cancer will still be expected to be alive after 5 years.

What is the pathological stage of cancer?

The pathological stage relies on the results of the exams and tests done before the surgery, as well as what is learned about the cancer during surgery. Sometimes, the pathological stage is different from the clinical stage (for instance, if the surgery shows the cancer has spread more than was seen on imaging tests).

How are tumors initiated in mice?

Induction of tumors in mouse skin. Tumors are initiated by mutations induced by a carcinogen. Development of a tumor then requires treatment with a tumor promoter to stimulate proliferation of the mutated cells. Hormones, particularly estrogens, are important as tumorpromoters in the development of some human cancers.

What is normal tissue?

Normal tissue is a mosaic of cells in which different X chromosomes (X1and X2) have been inactivated. Tumors develop from a single initially altered cell, so each tumor cell displays the same pattern of X inactivation (X1inactive, X (more...)

What is the fundamental abnormality resulting in the development of cancer?

The fundamental abnormality resulting in the development of cancer is the continual unregulated proliferation of cancer cells. Rather than responding appropriately to the signals that control normal cell behavior, cancer cells grow and divide in an uncontrolled manner, invading normal tissues and organs and eventually spreading throughout the body.

How do fibroblasts migrate?

Normal fibroblasts migrate across the surface of a culture dish until they make contact with a neighboring cell. Further cell migration is then inhibited, and normal cells adhere to each other, forming an orderly array of cells on the culture dish surface.

What are the different types of cancers?

Most cancers fall into one of three main groups: carcinomas, sarcomas, and leukemias or lymphomas. Carcinomas, which include approximately 90% of human cancers, are malignancies of epithelial cells.

What is the difference between sarcoma and leukemia?

Leukemiasand lymphomas, which account for approximately 8% of human malignancies, arise from the blood-forming cells and from cells of the immune system, respectively.

Why are cancer cells less adhesive than normal cells?

Most cancercells are less adhesive than normal cells, often as a result of reduced expression of cell surface adhesion molecules. For example, loss of E-cadherin, the principal adhesion molecule of epithelial cells, is important in the development of carcinomas (epithelial cancers).

What happens to a cell when it has mutations?

Once a critical mass of mutations affecting relevant processes is reached, the cell bearing the mutations acquires cancerous characteristics (uncontrolled division, evasion of apoptosis, capacity for metastasis, etc.) and is said to be a cancer cell. As a tumor progresses, its cells typically acquire more and more mutations.

What is the first step in a hypothetical series of mutations that might lead to cancer development?

In the first step, an initial mutation inactivates a negative cell cycle regulator. In one of the descendants of the original cell, a new mutation takes place, making a positive cell cycle regulator overly active.

What happens if one cell gets enough mutations?

Eventually, one cell might gain enough mutations to take on the characteristics of a cancer cell and give rise to a malignant tumor, a group of cells that divide excessively and can invade other tissues. Diagram of a hypothetical series of mutations that might lead to cancer development.

Why do cells have multiple mechanisms?

Cells have many different mechanisms to restrict cell division, repair DNA damage, and prevent the development of cancer. Because of this, it’s thought that cancer develops in a multi-step process, in which multiple mechanisms must fail before a critical mass is reached and cells become cancerous.

How many rounds of division do cancer cells go through?

In general, human cells can go through only about 40-60 rounds of division before they lose the capacity to divide, "grow old," and eventually die.

What is the process of cancer cells gaining oxygen and nutrients?

For instance, cancer cells gain the ability to migrate to other parts of the body, a process called metastasis, and to promote growth of new blood vessels, a process called angiogenesis (which gives tumor cells a source of oxygen and nutrients).

Why do cancer cells fail to undergo apoptosis?

Cancer cells also fail to undergo programmed cell death, or apoptosis, under conditions when normal cells would (e.g., due to DNA damage). In addition, emerging research shows that cancer cells may undergo metabolic changes that support increased cell growth and division.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9